BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
GLENMARK PHARMS LTD · BRIMONIDINE TARTRATE, TIMOLOL MALEATE
Open FDA's page for this record- Application number
- ANDA214987
- Sponsor name
- GLENMARK PHARMS LTD
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20240516
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Reference standard
- No
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- BRIMONIDINE TARTRATE
- Strength
- 0.2%
- Name
- TIMOLOL MALEATE
- Strength
- EQ 0.5% BASE
- Harmonized identifiers (openFDA)
- Application number
- ANDA214987
- Brand name
- BRIMONIDINE TARTRATE/TIMOLOL MALEATE
- Generic name
- BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Manufacturer name
- Glenmark Pharmaceuticals Inc., USA
- Product NDC
- 68462-281
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- OPHTHALMIC
- Substance name
- BRIMONIDINE TARTRATE, TIMOLOL MALEATE
- RxCUI
- 861635
- SPL ID
- e97c8703-5166-49b6-8dd2-69c5b9dfcae8
- SPL set ID
- bf6a7f59-5a10-49fe-9e57-19e3ba202918
- Package NDC
- 68462-281-69, 68462-281-32
- UNII
- 4S9CL2DY2H, P8Y54F701R
